THE NEED
In every surgical procedure, there is a need to close the incision. Current methods—stitching, gluing, and stapling— are time consuming, have large potential for infections, and leave a significant scar. Surgical procedures are becoming increasingly sophisticated and minimally invasive. The market is moving from general purpose sutures to dedicated devices and techniques targeted to the needs of the specific procedure.

 

 

THE PRODUCT
IonMed has developed a novel device that welds incisions using cold plasma and incorporates the use of a special albumin (protein). The procedure takes a few seconds, seals the area completely, leaves minimal scarring, and can be done without special training.

VALUE PROPOSITION
• Fast and easy to perform incision welding procedure
• Watertight sealing of the Incision, with less risk of infection
• Reduces healing time by improving the congealment
• Reduces tissue scaring

• There are around 73 million surgical wounds a year in the US alone.
• The current US wound closure market size is estimated to reach a size of  $3.4 billion by 2010

• The average annual growth of the wound closure market is 5.6%.

 

Amnon Lam, Founder and CEO, 10 years of experience with plasma processes development including R&D management with Tower semiconductors and Intel, M.S.c and B.S.c, in nuclear engineering from the Ben Gurion University.

Dr. Josef Haik, Medical Advisor, MD MPH, Specialist in Plastic Surgery, Director of the Intensive care burn unit, the department of plastic surgery at Sheba medical center, private practices in aesthetic and reconstructive surgery and wound care clinic at the Nara medical center and in Ramat Gan.

Dr.  Ephraim Sneh, M.D., Chairman Former Israeli Minister of Health, parliament member, and internationally recognized political analyst. Dr. Sneh brings many years of experience in management and healthcare.

Roni Bibi, Technology and Management Advisor